Vaxcyte, Inc. (PCVX) Q1 2024 Earnings
PCVX·Reported May 8, 2024·After market close
Diluted EPS came in at $-0.85, beat the $-1.13 consensus by $0.28.
Diluted EPS
$-0.85beat by $0.28
Consensus: $-1.13
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Vaxcyte, Inc.'s Q1 2024 earnings report.
Vaxcyte, Inc. (PCVX) reported Q1 2024 earnings on May 8, 2024 after market close.
Vaxcyte, Inc. reported diluted EPS of $-0.85 for Q1 2024.
EPS beat the consensus estimate of $-1.13 by $0.28.
You can read the 10-Q periodic report (0001628280-24-021677) directly on SEC EDGAR. The filing index links above go to sec.gov.